Another study demonstrates that the immunoreactivity for TrxR1 is observed in more than 50% of recurrent oligodendroglial tumours, which is 1.5 times of that in primary ones, indicating that TrxR1 plays a facilitative role in the malignant progression of oligodendrogliomas3. Here, TXNRD1 is linked to oligodendroglioma.